These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32708291)

  • 1. Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?
    Takigawa N; Ochi N; Nakagawa N; Nagasaki Y; Taoka M; Ichiyama N; Mimura A; Nakanishi H; Kohara H; Yamane H
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
    Meoni G; Cecere FL; Lucherini E; Di Costanzo F
    J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibitors in advanced non-small cell lung cancer.
    Assi HI; Kamphorst AO; Moukalled NM; Ramalingam SS
    Cancer; 2018 Jan; 124(2):248-261. PubMed ID: 29211297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.
    Tsukada H; Yokoyama A; Goto K; Shinkai T; Harada M; Ando M; Shibata T; Ohe Y; Tamura T; Saijo N;
    Jpn J Clin Oncol; 2015 Jan; 45(1):88-95. PubMed ID: 25378648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer.
    Leonetti A; Wever B; Mazzaschi G; Assaraf YG; Rolfo C; Quaini F; Tiseo M; Giovannetti E
    Drug Resist Updat; 2019 Sep; 46():100644. PubMed ID: 31585395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of advanced non-small-cell lung cancer in elderly populations.
    Lilenbaum R
    Clin Lung Cancer; 2003 Nov; 5(3):169-73. PubMed ID: 14667272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced Non-Small Cell Lung Cancer without epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations - Still a daily challenge.
    Su C; Zhou F; Shen J; Zhao J; O'Brien M
    Eur J Cancer; 2017 Sep; 83():266-278. PubMed ID: 28763691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immune checkpoint inhibitors in advanced non-small cell lung cancer.
    Pistamaltzian NF; Georgoulias V; Kotsakis A
    Expert Rev Respir Med; 2019 May; 13(5):435-447. PubMed ID: 30869543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly patients with lung cancer: biases and evidence.
    Langer CJ
    Curr Treat Options Oncol; 2002 Feb; 3(1):85-102. PubMed ID: 12057091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
    Weiss GJ; Langer C; Rosell R; Hanna N; Shepherd F; Einhorn LH; Nguyen B; Paul S; McAndrews P; Bunn PA; Kelly K
    J Clin Oncol; 2006 Sep; 24(27):4405-11. PubMed ID: 16983108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis.
    Dafni U; Tsourti Z; Vervita K; Peters S
    Lung Cancer; 2019 Aug; 134():127-140. PubMed ID: 31319971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderly.
    Sgambato A; Casaluce F; Gridelli C
    Expert Opin Biol Ther; 2017 May; 17(5):565-571. PubMed ID: 28276698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer.
    Pirker R
    Curr Opin Oncol; 2019 Jan; 31(1):24-28. PubMed ID: 30418192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors.
    Kim HK; Heo MH; Lee HS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):591-598. PubMed ID: 28733892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
    Herzberg B; Campo MJ; Gainor JF
    Oncologist; 2017 Jan; 22(1):81-88. PubMed ID: 27534574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor.
    Inomata M; Kado T; Okazawa S; Imanishi S; Taka C; Kambara K; Hirai T; Tanaka H; Tokui K; Hayashi K; Miwa T; Hayashi R; Matsui S; Tobe K
    Anticancer Res; 2019 Dec; 39(12):6887-6893. PubMed ID: 31810958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent topics in chemotherapy for elderly patients with lung cancer].
    Okamoto H; Watanabe K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
    Ikeda S; Yoshioka H; Ikeo S; Morita M; Sone N; Niwa T; Nishiyama A; Yokoyama T; Sekine A; Ogura T; Ishida T
    BMC Cancer; 2017 Nov; 17(1):797. PubMed ID: 29183294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of locally advanced non-small cell lung cancer in the elderly.
    Gridelli C; Maione P; Rossi A; Ciardiello F; Raben D
    Curr Opin Oncol; 2005 Mar; 17(2):130-4. PubMed ID: 15725917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.